ADDRESS-LC: study protocol for a phase 2, triple-blind, randomised, placebo-controlled trial to evaluate the efficacy and safety of bezisterim (NE3107) in adults with long COVID.

Triolex (bezisterim) - BioVie

http://www.ncbi.nlm.nih.gov/pubmed/42498469

Chantal M Petit; Christopher Reading; Clarence Ahlem; Jiayan Yan; Joseph M Palumbo; Lisa McCorkell; Michael J Peluso; Penelope Markham; Sherry Hsiang-Yi Chou; Stephen O'Quinn

Jul 25, 2026